Next Article in Journal
Fatal Human Case of Zika and Chikungunya Virus Co-Infection with Prolonged Viremia and Viruria
Next Article in Special Issue
Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era
Previous Article in Journal / Special Issue
Adverse Effects of Direct Acting Antivirals in HIV/HCV Coinfected Patients: A 4-Year Experience in Miami, Florida
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessFeature PaperReview
Diseases 2018, 6(2), 52; https://doi.org/10.3390/diseases6020052

Renal Impairment in Chronic Hepatitis B: A Review

Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
*
Author to whom correspondence should be addressed.
Received: 15 May 2018 / Revised: 4 June 2018 / Accepted: 4 June 2018 / Published: 19 June 2018
(This article belongs to the Special Issue Hepatitis and Treatment)
Full-Text   |   PDF [1213 KB, uploaded 21 June 2018]   |  

Abstract

The liver plays a key role in the metabolism of proteins. Liver dysfunction affects many organs because it communicates with the spleen and all digestive organs through the portal vein. Additionally, the kidney is an organ that is closely related to the liver and is involved in liver diseases. Glomerulonephritis is an important extrahepatic manifestation of chronic hepatitis B virus (HBV) infection. Nucleos(t)ide analog (NA) therapy effectively suppresses HBV replication by inhibiting HBV polymerase, thus decreasing the levels of serum HBV-DNA and delaying the progression of cirrhosis. Although NA therapy is recommended for all patients with chronic HBV infection, regardless of the level of renal dysfunction, there is limited information on NA use in patients with chronic kidney disease. In addition, in patients with end-stage liver cirrhosis, hepatorenal syndrome can be fatal. Hence, we should take into account the stage of impaired renal function in patients with cirrhosis. The aims of this article are to review the epidemiology, clinical presentation, treatment, and prevention of HBV-associated nephropathy. View Full-Text
Keywords: hepatitis B; hepatorenal syndrome; HBV-associated glomerulonephritis hepatitis B; hepatorenal syndrome; HBV-associated glomerulonephritis
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Kamimura, H.; Setsu, T.; Kimura, N.; Yokoo, T.; Sakamaki, A.; Kamimura, K.; Tsuchiya, A.; Takamura, M.; Yamagiwa, S.; Terai, S. Renal Impairment in Chronic Hepatitis B: A Review. Diseases 2018, 6, 52.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top